A phase II, randomized, double-blind, placebo-controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: A Gynecologic Oncology Group partners study
Monk, B.J., Brady, M.F., Aghajanian, C., Lankes, H., Rizack, T., Leach, J.W., Fowler, J.M., Higgins, R.V., Hanjani, P., Morgan, M.A.Volume:
145
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2017.03.507
Date:
June, 2017
File:
PDF, 56 KB
english, 2017